Trial Profile
A phase I/II trial of FPX-01 for cancer treatment
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 27 Sep 2017
Price :
$35
*
At a glance
- Drugs 225 Actinium FPI 1434 (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Sep 2017 This trial is expected to begin in early 2018, according to a Fusion Pharmaceuticals media release.
- 30 Dec 2015 New trial record